MIRANDA TERRES: Open Payments
NPI 1114521069 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,425 in 133 payments from 21 companies in 2025. Trend: 2023 $517 · 2024 $958 · 2025 $3,425
Food & beverage: $3,425
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $638 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $424 |
| Phathom Pharmaceuticals, Inc. | 15 | $392 |
| GENZYME CORPORATION | 7 | $230 |
| Gilead Sciences, Inc. | 6 | $227 |
| Janssen Biotech, Inc. | 6 | $226 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $172 |
| PFIZER INC. | 7 | $169 |
| Celltrion USA Inc. | 7 | $150 |
| Madrigal Pharmaceuticals | 4 | $139 |
Products named: VOQUEZNA, ENTYVIO, DUPIXENT, CREON, TREMFYA, RINVOQ, XIFAXAN, VEGZELMA.
Industry payments across FL — which companies pay providers there.
